Media Releases

10 May, 2017

The Royal College of Pathologists of Australasia (RCPA) strongly supports the Federal Government's new measure, 'Pathology Approved Collection Centres - strengthening Compliance', which was announced last night as part of the 2017-2018 Federal Budget.

16 November, 2016

Today, pathologists, scientists and laboratories around the globe - Australia, New Zealand, Hong Kong, Singapore, Malaysia, the UK, Ireland, the USA, Canada, and South Africa – gathered to celebrate International Pathology Day (IPD) 2016.

16 November, 2016

The Royal College of Pathologists of Australasia (RCPA) has today released a new position statement and comprehensive checklist which outlines patients’ expectations of pathologists and the pathology profession. The checklist was developed in close collaboration with the RCPA’s dedicated Lay Advisory Committee, and will be utilised to develop and revise future curricula for the training of new pathologists. The collaborative approach of the RCPA and the Lay Advisory Committee is the first of its kind and has identified consumers’ expectations of pathologists, which is a completely new approach.

16 November, 2016

The Royal College of Pathologists of Australasia (RCPA) has announced a new position statement, outlining its recommendations on the requesting, testing and reporting of serum tumour markers, specifically related to the testing of serum specimens (not urine, tissue or cells). The appropriate use of tumour marker testing is complex and the new guidelines have been created to reduce the risk of patient harm which may occur when testing is performed inappropriately. The recommendations do not include markers such as prostate specific antigen or hormones, although the principles described with respect to tumour marker testing and the reporting of results may still apply.

16 November, 2016

The Royal College of Pathologists of Australasia (RCPA) has today released a new position statement, detailing its guidelines for a defined list of pathology tests that are required to monitor diabetes effectively. The RCPA recommends an annual monitoring care set for adult stable diabetes which includes tests for the following: Creatinine, cholesterol, triglycerides; HDL cholesterol; Microalbumin; and HbA1c. Diabetes prevention programs such as this, aims to assist in limiting the number of potentially preventable hospitalisations for chronic conditions linked to diabetes. By defining guidelines for the healthcare profession to monitor adult stable diabetes, the RCPA hopes to improve patient care and lead to better controls and lower complication rates.


Displaying results 31 - 35 of 35

Page last updated:

Copyright © 2020 RCPA. All rights reserved.

Top